Skip to main content
Premium Trial:

Request an Annual Quote

Pressure Biosciences Inks CRADA

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure Biosciences today said it has signed a Cooperative Research and Development Agreement with the Armed Forces Institute of Pathology, the American Registry of Pathology, and the Department of Veterans Affairs to develop pressure-based sample preparation methods for formalin-fixed paraffin embedded tissue.

The CRADA is directed at improving the quality and yield of biomolecular extractions, such as proteins, DNA, and RNA, from archival FFPE tissue samples, PBI said in a statement.

While formalin fixation followed by paraffin embedding is one of the most commonly used methods for preserving tissues for pathology evaluation, FFPE tissue poses significant challenges for the extraction of biomolecules, and formalin can result in the loss of biomolecules in the sample, PBI said.

"If these effects can be overcome, today's very sensitive and sophisticated analytical techniques could be used to study millions of archived FFPE samples," leading to the discovery of new biomarkers and the development of new interventions for cancer and other diseases, Timothy J. O'Leary, deputy chief research and development officer for the VA, said.

Terms of the CRADA were not disclosed.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.